Synonym
ST-198; ST 198; ST198.
IUPAC/Chemical Name
(E)-N-[4-(3,4-dihydro-1H-isoquinolin-2-yl)butyl]-3-phenylprop-2-enamide
InChi Key
GQPJBOOQHWEOKT-OUKQBFOZSA-N
InChi Code
InChI=1S/C22H26N2O/c25-22(13-12-19-8-2-1-3-9-19)23-15-6-7-16-24-17-14-20-10-4-5-11-21(20)18-24/h1-5,8-13H,6-7,14-18H2,(H,23,25)/b13-12+
SMILES Code
O=C(NCCCCN1CC2=C(C=CC=C2)CC1)/C=C/C3=CC=CC=C3
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
334.46
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B.
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor
neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci.
2009 Apr 15;29(15):4829-35. doi: 10.1523/JNEUROSCI.5884-08.2009. PubMed PMID:
19369551.
2: Le Foll B, Sokoloff P, Stark H, Goldberg SR. Dopamine D3 receptor ligands
block nicotine-induced conditioned place preferences through a mechanism that
does not involve discriminative-stimulus or antidepressant-like effects.
Neuropsychopharmacology. 2005 Apr;30(4):720-30. PubMed PMID: 15562293.
3: Bézard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P.
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor
function. Nat Med. 2003 Jun;9(6):762-7. Epub 2003 May 12. PubMed PMID: 12740572.
4: Weber B, Schlicker E, Sokoloff P, Stark H. Identification of the dopamine
autoreceptor in the guinea-pig retina as D(2) receptor using novel
subtype-selective antagonists. Br J Pharmacol. 2001 Aug;133(8):1243-8. PubMed
PMID: 11498509; PubMed Central PMCID: PMC1621144.
